FindTrial
Sign In

Influence of a food product containing a high amount od 1-kestose on intestinal commensals in Crohn's disease

Influence of a food product containing a high amount od 1-kestose on intestinal commensals in Crohn's disease - kestose trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039792
Enrollment
20
Registered
2020-03-12
Start date
2019-07-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

dayly uptake of 1-kestose containing food

Sponsors

Internal Medicine (gastroenterlogy) Tokai University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 16 years old or older 2) 220 or less of CDAI score 3) no chenge of the treatment of Crohn's diease in the past 1 month and no plan of the change during the 4 months of 1-kestose uptake

Exclusion criteria

Exclusion criteria: 1) antibiotics usage of 3 days or more after the registration 2) antiacids uptake such as proton pump inhibitors usage of 7 or more consectutive days 3) treatment change for Crohn's disease after the registration 4) regularly taking pre- or probiotics after the registration 5) not proper case for some medical reasons by the attended physician

Design outcomes

Primary

MeasureTime frame
the intestinal commensals of 2 and 4 months after starting daily uptake of 1-ketose compared with before and 2 months after the uptake—

Secondary

MeasureTime frame
CDAI scores of 2 and 4 months after starting daily uptake of 1-ketose compared with before and 2 months after the uptake—

Countries

Japan

Contacts

Public ContactMasashi Matsushima

Tokai University School of Medicine Internal Medicine (gastroenterlogy)

mmatsush@tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026